| Identifiers | |
|---|---|
| |
| CAS Number | |
| PubChemCID | |
| ChemSpider | |
| UNII | |
| Chemical and physical data | |
| Formula | C22H20FN3O2 |
| Molar mass | 377.419 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
GRC-6211 is a drug developed byGlenmark Pharmaceuticals which acts as a potent and selectiveantagonist for theTRPV1 receptor. It hasanalgesic andantiinflammatory effects and reachedPhase IIb human trials, but was ultimately discontinued from development as a medicine, though it continues to have applications in scientific research.[1][2][3]
Thispharmacology-related article is astub. You can help Wikipedia byexpanding it. |